Cargando…

Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain

BACKGROUND: Thiazolidinediones are antidiabetic agents that increase insulin sensitivity but reduce glucose oxidation, state 3 respiration, and activity of complex I of the mitochondrial respiratory chain (MRC). The mechanisms of the latter effects are unclear. The aim of this study was to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Ruiz, Inmaculada, Solís-Muñoz, Pablo, Fernández-Moreira, Daniel, Muñoz-Yagüe, Teresa, Solís-Herruzo, José A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751493/
https://www.ncbi.nlm.nih.gov/pubmed/23915000
http://dx.doi.org/10.1186/1741-7007-11-88
_version_ 1782281609263710208
author García-Ruiz, Inmaculada
Solís-Muñoz, Pablo
Fernández-Moreira, Daniel
Muñoz-Yagüe, Teresa
Solís-Herruzo, José A
author_facet García-Ruiz, Inmaculada
Solís-Muñoz, Pablo
Fernández-Moreira, Daniel
Muñoz-Yagüe, Teresa
Solís-Herruzo, José A
author_sort García-Ruiz, Inmaculada
collection PubMed
description BACKGROUND: Thiazolidinediones are antidiabetic agents that increase insulin sensitivity but reduce glucose oxidation, state 3 respiration, and activity of complex I of the mitochondrial respiratory chain (MRC). The mechanisms of the latter effects are unclear. The aim of this study was to determine the mechanisms by which pioglitazone (PGZ), a member of the thiazolidinedione class of antidiabetic agents, decreases the activity of the MRC. In isolated mitochondria from mouse liver, we measured the effects of PGZ treatment on MRC complex activities, fully-assembled complex I and its subunits, gene expression of complex I and III subunits, and [(3)H]PGZ binding to mitochondrial complexes. RESULTS: In vitro, PGZ decreased activity of complexes I and III of the MRC, but in vivo only complex I activity was decreased in mice treated for 12 weeks with 10 mg/kg/day of PGZ. In vitro treatment of isolated liver mitochondria with PGZ disassembled complex I, resulting in the formation of several subcomplexes. In mice treated with PGZ, fully assembled complex I was increased and two additional subcomplexes were found. Formation of supercomplexes CI+CIII(2)+CIV(n) and CI+CIII(2) decreased in mouse liver mitochondria exposed to PGZ, while formation of these supercomplexes was increased in mice treated with PGZ. Two-dimensional analysis of complex I using blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) showed that in vitro PGZ induced the formation of four subcomplexes of 600 (B), 400 (C), 350 (D), and 250 (E) kDa, respectively. Subcomplexes B and C had NADH:dehydrogenase activity, while subcomplexes C and D contained subunits of complex I membrane arm. Autoradiography and coimmunoprecipitation assays showed [(3)H]PGZ binding to subunits NDUFA9, NDUFB6, and NDUFA6. Treatment with PGZ increased mitochondrial gene transcription in mice liver and HepG2 cells. In these cells, PGZ decreased intracellular ATP content and enhanced gene expression of specific protein 1 and peroxisome-proliferator activated receptor (PPAR)γ coactivator 1α (PGC-1α). CONCLUSIONS: PGZ binds complex I subunits, which induces disassembly of this complex, reduces its activity, depletes cellular ATP, and, in mice and HepG2 cells, upregulates nuclear DNA-encoded gene expression of complex I and III subunits.
format Online
Article
Text
id pubmed-3751493
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37514932013-08-24 Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain García-Ruiz, Inmaculada Solís-Muñoz, Pablo Fernández-Moreira, Daniel Muñoz-Yagüe, Teresa Solís-Herruzo, José A BMC Biol Research Article BACKGROUND: Thiazolidinediones are antidiabetic agents that increase insulin sensitivity but reduce glucose oxidation, state 3 respiration, and activity of complex I of the mitochondrial respiratory chain (MRC). The mechanisms of the latter effects are unclear. The aim of this study was to determine the mechanisms by which pioglitazone (PGZ), a member of the thiazolidinedione class of antidiabetic agents, decreases the activity of the MRC. In isolated mitochondria from mouse liver, we measured the effects of PGZ treatment on MRC complex activities, fully-assembled complex I and its subunits, gene expression of complex I and III subunits, and [(3)H]PGZ binding to mitochondrial complexes. RESULTS: In vitro, PGZ decreased activity of complexes I and III of the MRC, but in vivo only complex I activity was decreased in mice treated for 12 weeks with 10 mg/kg/day of PGZ. In vitro treatment of isolated liver mitochondria with PGZ disassembled complex I, resulting in the formation of several subcomplexes. In mice treated with PGZ, fully assembled complex I was increased and two additional subcomplexes were found. Formation of supercomplexes CI+CIII(2)+CIV(n) and CI+CIII(2) decreased in mouse liver mitochondria exposed to PGZ, while formation of these supercomplexes was increased in mice treated with PGZ. Two-dimensional analysis of complex I using blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) showed that in vitro PGZ induced the formation of four subcomplexes of 600 (B), 400 (C), 350 (D), and 250 (E) kDa, respectively. Subcomplexes B and C had NADH:dehydrogenase activity, while subcomplexes C and D contained subunits of complex I membrane arm. Autoradiography and coimmunoprecipitation assays showed [(3)H]PGZ binding to subunits NDUFA9, NDUFB6, and NDUFA6. Treatment with PGZ increased mitochondrial gene transcription in mice liver and HepG2 cells. In these cells, PGZ decreased intracellular ATP content and enhanced gene expression of specific protein 1 and peroxisome-proliferator activated receptor (PPAR)γ coactivator 1α (PGC-1α). CONCLUSIONS: PGZ binds complex I subunits, which induces disassembly of this complex, reduces its activity, depletes cellular ATP, and, in mice and HepG2 cells, upregulates nuclear DNA-encoded gene expression of complex I and III subunits. BioMed Central 2013-08-01 /pmc/articles/PMC3751493/ /pubmed/23915000 http://dx.doi.org/10.1186/1741-7007-11-88 Text en Copyright © 2013 García-Ruiz et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
García-Ruiz, Inmaculada
Solís-Muñoz, Pablo
Fernández-Moreira, Daniel
Muñoz-Yagüe, Teresa
Solís-Herruzo, José A
Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain
title Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain
title_full Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain
title_fullStr Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain
title_full_unstemmed Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain
title_short Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain
title_sort pioglitazone leads to an inactivation and disassembly of complex i of the mitochondrial respiratory chain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751493/
https://www.ncbi.nlm.nih.gov/pubmed/23915000
http://dx.doi.org/10.1186/1741-7007-11-88
work_keys_str_mv AT garciaruizinmaculada pioglitazoneleadstoaninactivationanddisassemblyofcomplexiofthemitochondrialrespiratorychain
AT solismunozpablo pioglitazoneleadstoaninactivationanddisassemblyofcomplexiofthemitochondrialrespiratorychain
AT fernandezmoreiradaniel pioglitazoneleadstoaninactivationanddisassemblyofcomplexiofthemitochondrialrespiratorychain
AT munozyagueteresa pioglitazoneleadstoaninactivationanddisassemblyofcomplexiofthemitochondrialrespiratorychain
AT solisherruzojosea pioglitazoneleadstoaninactivationanddisassemblyofcomplexiofthemitochondrialrespiratorychain